Accuracy Coverage Pricing Contact
Circassia Pharmaceuticals

Circassia Pharmaceuticals (CIR)

Circassia develops short-course allergy therapies and a range of asthma treatments. It has a broad range of treatments in development, with many in late-stage clinical studies.  

The most advanced allergy therapy is currently undergoing phase III testing, and their asthma treatment is undergoing regulatory review.

Circassia regularly publishes its scientific progress in peer-reviewed journals, and presents results at leading scientific conferences.

Fundamentals

Optimized Dividends

Annual Dividends

Year Amount Change
2006 0.0p
2007 0.0p 0%
2008 0.0p 0%
2009 0.0p 0%

Dividends

Ex-Div Date Pay Date Year Type Frequency Status Amount

Recent news articles

Investment Tools Limited

OPERATIONAL HIGHLIGHTS

Read more

Circassia Pharmaceuticals optimized dividend - 12 month history

Optimized dividend graph demo

Circassia Pharmaceuticals share price - 12 month history

You're currently viewing outdated and/or artificial data.

Try the real thing now:

Activate Free Trial